| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |